Ran Schwarzkopf, MD | NYU Langone Health

Dr. Ran Schwarzkopf, MD

Claim this profile

NYU Langone Health

Studies Osteoarthritis Treatment Costs
Studies Osteoarthritis
12 reported clinical trials
18 drugs studied

Affiliated Hospitals

Image of trial facility.
NYU Langone Health
Image of trial facility.
New York University Dept Of Orthopedic Surgery

Clinical Trials Ran Schwarzkopf, MD is currently running

Image of trial facility.

Nutritional Supplements

for Joint Replacement Recovery

The purpose of this study is to determine the effect on hematological markers of nutritional intervention on nutritionally deficient patients following total joint replacement surgery.
Recruiting1 award N/A1 criteria
Image of trial facility.

Bone Marrow Aspirate

for Osteonecrosis

Osteonecrosis of the femoral head (ONFH) is a debilitating musculoskeletal disease that is characterized by localized death of bone cells and associated cellular elements within the subchondral bone. If it progresses, it results in the collapse of the femoral head (ball part of the hip) giving rise to secondary arthritis. This condition is associated with marked pain and loss of function, often necessitating a joint replacement. Due to the relatively young age of onset of ONFH (often in 20s and 30s), there is great interest in utilizing joint-preserving procedures prior to the need for joint replacement. Joint-preserving procedures include core decompression (CD) with and without bone grafts or cells, vascularized and non-vascularized bone grafting, as well as osteotomies. Inconsistent results for each of these procedures have been reported and there are no Clinical Practice Guidelines or medical community consensus opinions regarding the treatment of early-stage ONFH. The hypothesis to be tested is "Participants who have early-stage ONFH undergoing CD augmented with autogenous bone marrow aspirate concentrate will have better clinical and radiological outcomes than CD alone." This multi-center randomized controlled trial for early-stage ONFH is prospective and controlled for participant stage (only early-stage pre-collapse individuals) and surgical technique. Participants will be evaluated as per routine surgical follow-up, and at 6 months (telemedicine), 1- and 2- years using radiographs, MRIs, and questionnaires. This project will also explore the scientific basis for success vs. failure in individuals who have osteonecrosis, and have different demographics and bone marrow aspirate cell profiles.
Recruiting1 award N/A7 criteria

More about Ran Schwarzkopf, MD

Clinical Trial Related10 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Ran Schwarzkopf, MD has experience with
  • Two-stage Exchange Arthroplasty
  • VT-X7 Treatment System
  • Conventional
  • Povidone Iodine
  • Vancomycin Powder
  • Ensure

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Ran Schwarzkopf, MD specialize in?
Is Ran Schwarzkopf, MD currently recruiting for clinical trials?
Are there any treatments that Ran Schwarzkopf, MD has studied deeply?
What is the best way to schedule an appointment with Ran Schwarzkopf, MD?
What is the office address of Ran Schwarzkopf, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security